Many patent applicants currently face difficulty in obtaining antibody claims because of written description and enablement ...

A team of scientists has uncovered the remarkable potential of a human antibody, mAb 3A6, in fighting Ebola virus infections.

The US Food and Drug Administration (FDA) has approved an investigational new drug (IND) application from Aclaris ...